单位：人民币元
                                     本报告期末        上年度期末
总资产                         7,307,464,432.38  7,434,985,230.95
所有者权益(或股东权益)         3,842,245,712.81  3,872,266,150.87
每股净资产                                 3.10              3.13
                                  报告期(1-6月)          上年同期
营业收入                       1,901,968,033.65  1,827,419,868.64
净利润                           496,229,965.59    202,648,053.14
扣除非经常性损益后的净利润       209,330,556.05    188,402,536.29
基本每股收益                               0.40              0.16
扣除非经常性损益后的基本每股收益           0.17              0.15
净资产收益率(%)                           12.92              6.21
每股经营活动产生的现金流量净额             0.07              0.00
→查看复星医药详细信息